Gilda Neves Selected Research

LASSBio-581

5/2010	Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581.
3/2008	Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilda Neves Research Topics

Disease

5	Schizophrenia (Dementia Praecox) 07/2017 - 03/2008
1	Infections 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Catalepsy 01/2013

Drug/Important Bio-Agent (IBA)

4	phenylpiperazineIBA 01/2013 - 03/2008
2	LASSBio-579IBA 01/2013 - 03/2008
2	LASSBio-581IBA 05/2010 - 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Ketamine FDA LinkGeneric 07/2017
1	Anesthetics (Anesthetic Agents)IBA 07/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2017
1	5-HT1A Serotonin ReceptorIBA 01/2013
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2013
1	Apomorphine FDA Link 01/2013
1	Clozapine (Clozaril)FDA LinkGeneric 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Haloperidol (Haldol)FDA LinkGeneric 01/2013
1	Hypnotics and Sedatives (Sedatives)IBA 01/2013
1	LigandsIBA 01/2013
1	Antipsychotic Agents (Antipsychotics)IBA 01/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2008
1	Dopamine (Intropin)FDA LinkGeneric 03/2008